Westborough, MA, United States of America

Paul Rafferty

This inventor holds 22 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent, primarily in Kinase Inhibitors. Top assignees: Abbott Laboratories Corporation, Abbott Gmbh & Co Kg, Knoll Aktiengesellschaft. Active years: 1998-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Rafferty. Retrieved from https://idiyas.com/inventor/paul-rafferty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22

% Patents Active = 90.9

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 1

Average Co-Inventor Count = 5.7

ph-index = 10

Forward Citations = 1,065(Granted Patents)

Location History:

Nottingham, GB (1998 - 2011)
Westborough, MA (US) (2001 - 2012)

Company Filing History:

7 out of 4,190

Abbott Laboratories Corporation

Knoll Aktiengesellschaft

patents

4. 4 out of 10,816

Basf Aktiengesellschaft

patents

Years Active: 1998-2012

Loading Chart...

Areas of Expertise:

Thienopyridine

Furopyridine

Kinase Inhibitors

Pyrazolopyrimidine

Imidazole Derivatives

Tricyclic Pyrazole

2-Pyrazolin-5-Ones

Phenoxy Compounds

Arachidonic Acid

Pyrrolopyrimidines

Therapeutic Agents

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8273736 - Thienopyridine and furopyridine kinase inhibitors (2012-09-25),

2. 7863444 - 4-aminopyrrolopyrimidines as kinase inhibitors (2011-01-04),

3. 7737160 - Thienopyridine and furopyridine kinase inhibitors (2010-06-15),

4. 7468371 - Tricyclic pyrazole kinase inhibitors (2008-12-23),

5. 7332497 - Pyrazolopyrimidines as therapeutic agents (2008-02-19),

6. 7202363 - Thienopyridine and furopyridine kinase inhibitors (2007-04-10),

7. 7071199 - Kinase inhibitors as therapeutic agents (2006-07-04),

8. 7060822 - 2-pyrazolin-5-ones (2006-06-13),

9. 7049312 - Benzothiazinone and benzoxazinone compounds (2006-05-23),

10. 6921763 - Pyrazolopyrimidines as therapeutic agents (2005-07-26),

11. 6713474 - Pyrrolopyrimidines as therapeutic agents (2004-03-30),

12. 6660744 - Pyrazolopyrimidines as therapeutic agents (2003-12-09),

13. 6534655 - Indeno[1,2-C]pyrazole derivatives for inhibiting tyrosine kinase activity (2003-03-18),

14. 6462036 - Tricyclic pyrazole derivatives (2002-10-08),

15. 6326500 - Imidazole derivatives for blocking the release of arachidonic acid from phospholipids (2001-12-04),

Title: The Innovative Journey of Paul Rafferty

Introduction: Paul Rafferty, a talented inventor hailing from Westborough, MA (US), has made significant contributions to the world of innovations with his creative mind and dedication.

Latest Patents: Paul Rafferty holds several patents in various fields, showcasing his versatility and expertise in inventing cutting-edge solutions to real-world problems.

Career Highlights: Throughout his career, Paul Rafferty has demonstrated a keen eye for identifying gaps in the market and developing unique inventions to fill those voids. His innovative spirit has led to the creation of groundbreaking technologies that have revolutionized industries.

Collaborations: Paul Rafferty has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Paul Rafferty's passion for innovation, coupled with his determination to make a difference, has established him as a prominent figure in the world of inventors. His contributions continue to inspire future generations to push the boundaries of what is possible through creativity and ingenuity.

Profile summary based on public USPTO records.